30P Pan-immune inflammation value (PIV): A predictive marker of response to neo-adjuvant chemotherapy (NACT) in locally advanced breast cancer (LABC)
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.10.051
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
0
Citations
0
h-index
0
i10-index
Manjunath S Hiremani is an academic researcher from Kidwai Memorial Institute of Oncology. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Inflammatory Biomarkers in Disease Prognosis & Lung Cancer Diagnosis and Treatment.
Click to start Chat